Patients asking about APOE gene test results? Here's what to tell them

Shana D Stites; Nicholas M Vogt; Deborah Blacker; Malia Rumbaugh; Monica W Parker; Advisory Group on Risk Evidence Education for Dementia (AGREED)

doi:10.12788/jfp.0397

Patients asking about APOE gene test results? Here's what to tell them

J Fam Pract. 2022 May;71(4):E1-E7. doi: 10.12788/jfp.0397.

Authors

Shana D Stites¹, Nicholas M Vogt¹, Deborah Blacker¹, Malia Rumbaugh¹, Monica W Parker¹; Advisory Group on Risk Evidence Education for Dementia (AGREED)¹

Affiliation

¹ Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Dr. Stites); Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison (Dr. Vogt); Department of Psychiatry, Mass General Hospital Harvard Medical School and Department of Epidemiology, Harvard TH Chan School of Public Health, Boston (Dr. Blacker); Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis (Dr. Rumbaugh); Goizueta Alzheimer's Disease Research Center, Emory University, Atlanta, GA (Dr. Parker).

Abstract

This guidance can help shape the conversations you have with patients who want to understand the results of their gene and biomarker testing for Alzheimer disease.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Apolipoproteins E* / genetics
Humans

Substances

Apolipoproteins E

Abstract

Publication types

MeSH terms

Substances

Grants and funding